Long Island Skin Cancer and Dermatologic Surgery — Smithtown, New York

Long Island Skin Cancer and Dermatologic Surgery is a clinical research site located in Smithtown, New York, United States 11787.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Long Island Skin Cancer and Dermatologic Surgery has participated in 5 clinical trials.

Therapeutic areas: Basal Cell Carcinoma, Actinic Keratosis.

Sponsors: Hoffmann-La Roche, LEO Pharma, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Long Island Skin Cancer and Dermatologic Surgery?

Long Island Skin Cancer and Dermatologic Surgery has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Long Island Skin Cancer and Dermatologic Surgery conducted?

Long Island Skin Cancer and Dermatologic Surgery has 5 clinical trials on record. Their work covers Basal Cell Carcinoma, Actinic Keratosis.

Is Long Island Skin Cancer and Dermatologic Surgery accredited by Crixeo Health?

Long Island Skin Cancer and Dermatologic Surgery has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Long Island Skin Cancer and Dermatologic Surgery?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.